Helena Anglada-Martínez

Learn More
The aim of this study was to assess the feasibility and preliminary outcomes of a medication self-management platform for chronically ill patients, Medplan. We performed a 6-month single-arm prospective pre-post intervention study of patients receiving treatment for hypertension and/or dyslipidemia and/or heart failure and/or human immunodeficiency virus(More)
INTRODUCTION mTOR (mammalian target of rapamycin) inhibitors sirolimus and everolimus, used as immunosuppressants in solid organ transplantation, may cause severe adverse effects, such as interstitial pneumonitis. INCIDENCE AND CLINICAL PRESENTATION: The estimated incidence of interstitial pneumonitis is 4-11% although it may be higher. Most reported cases(More)
Background Zoledronic acid (ZA) is an intravenous bisphosphonate approved for the prevention and treatment of cancer skeletal-related events. Objective Our aim was to analyze the prescription patterns of ZA in the cancer outpatient clinic. Method We performed a retrospective chart review of all patients who received at least 1 dose of ZA from January 2009(More)
WHAT IS KNOWN AND OBJECTIVE It is now estimated that about 5% of cetuximab-treated patients and about 3% of panitumumab-treated patients will develop grade 3-4 hypomagnesemia. The aim of this study was to assess the extent of magnesium monitoring in patients treated with epidermal growth factor receptor (EGFR)-targeting antibodies and to estimate the(More)
OBJECTIVES Mobile phones have been rapidly adopted by the general population and are now a promising technology with considerable potential in health care. However, refusal rates of 24%-75% have been reported in telemedicine studies. We aimed to report the challenges faced when recruiting patients to use Android and iOS smartphone applications aimed at(More)
Numerous novel oral antineoplasic agents (OAA) have been approved over the past few years. They are considered to be high risk drugs and since their commercialization, numerous medication errors have been detected. Consequently, new challenges regarding their monitorization, possible drug interactions and patient ́s adherence have arisen. The information(More)
AIMS Adherence to medication is a major problem that affects 50-60% of chronically ill patients. As mobile phone use spreads rapidly, a new model of remote health delivery via mobile phone – mHealth – is increasingly used. The objective of this study is to provide a comprehensive overview of how mHealth can be used to improve adherence to medication. (More)
Background It is not unusual to find obese and cachectic patients in the hematology oncology setting. However, information on dosage in these groups is scarce. Objective The objectives of our study were to explore the dosing strategies applied in the treatment of obese and cachectic cancer patients and to determine whether these strategies are applied in(More)
A systematic review was conducted to know the state of the art in this field. Subsequently, Medplan platform was designed and developed by a multidisciplinary team composed of hospital pharmacist, primary care physicians, specialist physicians, patients and developers. Medplan was then tested by creating 5 fictitious patients using the white and black-box(More)
Poor adherence to medication is a prevalent issue that affects 50–60% of chronically ill patients. We present Medplan, a platform for patients/caregivers and healthcare professionals (HCPs) that aims to enhance adherence, increase patient medication knowledge, and facilitate communication between patients and HCPs. The Medplan platform was designed and(More)
  • 1